comparemela.com

Latest Breaking News On - Amneal pharmaceuticals inc - Page 4 : comparemela.com

North American Morning Briefing : Apple, Amgen -2-

The asset manager s financing-heavy investments jumped 52% to $18.6 billion this year through March from $12.2 billion in the year-earlier period, a presentation of the firm s first-quarter results. -May 03, 2024 at 06:09 am EDT - MarketScreener

Motion Sickness Drugs Market size to record USD 136 49 million growth from 2023-2027, Advent of nauseogenic information technology is one of the key market trends, Technavio

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement

Friday, Amneal Pharmaceuticals Inc AMRX announced a significant agreement valued at over $270 million to settle claims related to its alleged contribution to…

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement - Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals settles $270 million opioid crisis agreement, offering cash and naloxone spray. Boosted by strong Q1 earnings, the company reaffirms fiscal guidance.

Amneal Pharmaceuticals (AMRX) Scheduled to Post Quarterly Earnings on Friday

Amneal Pharmaceuticals (NASDAQ:AMRX – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, May 3rd. Analysts expect the company to announce earnings of $0.08 per share for the quarter. Amneal Pharmaceuticals has set its FY 2024 guidance at 0.530-0.630 EPS.Parties that are interested in participating in […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.